1. Home
  2. MXCT vs CODA Comparison

MXCT vs CODA Comparison

Compare MXCT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.10

Market Cap

136.2M

Sector

Health Care

ML Signal

N/A

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

N/A

Current Price

$10.70

Market Cap

114.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MXCT
CODA
Founded
1999
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.2M
114.7M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
MXCT
CODA
Price
$1.10
$10.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$4.11
★ $14.00
AVG Volume (30 Days)
★ 325.0K
115.9K
Earning Date
11-04-2026
09-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 15.62
EPS
N/A
★ 0.36
Revenue
★ $33,026,000.00
$20,316,161.00
Revenue This Year
N/A
$9.92
Revenue Next Year
$18.24
$17.26
P/E Ratio
★ N/A
$30.44
Revenue Growth
N/A
★ 4.98
52 Week Low
$0.64
$7.80
52 Week High
$1.86
$18.00

Technical Indicators

Market Signals
Indicator
MXCT
CODA
Relative Strength Index (RSI) 41.47 53.88
Support Level $1.11 $9.82
Resistance Level $1.16 $11.38
Average True Range (ATR) 0.05 0.43
MACD -0.01 -0.01
Stochastic Oscillator 15.38 60.48

Price Performance

Historical Comparison
MXCT
CODA

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: